Psychiatry and Neurology, Neurology · Rochester, NY
NPI
1295051886
Since 2010
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
3
Medicare group memberships
Hospitals
1
Hospital affiliations
919 Westfall Rd, Bldg. C - Suite 220
Rochester, NY, 14618
Phone (585) 341-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$59K
4,992 services
Medicare patients, 2024
154
Average age 69
Drug cost, 2024
$2.6M
2,524 prescriptions
Company payments, 2025
$32K
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kelly L Andrzejewski was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 117 times for 65 patients. In total Kelly L Andrzejewski billed 4,992 services in 36 codes, and Medicare paid $59K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-07-01.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 117 | 65 | $12.65 | $1,480 |
| 99214 Office E&M - Established | Office | 107 | 69 | $88.68 | $9,488 |
| 99215 Office E&M - Established | Office | 45 | 32 | $136.94 | $6,162 |
| 95970 Electrical Nerve Conductivity | Office | 29 | 16 | $13.74 | $398 |
| 99213 Office E&M - Established | Office | 28 | 20 | $58.50 | $1,638 |
| 99232 Hospital E&M - Subsequent | Facility | 26 | 16 | $64.30 | $1,672 |
| 95983 Electrical Nerve Conductivity | Office | 18 | 11 | $31.66 | $570 |
| 99222 Hospital E&M - Initial | Facility | 17 | 17 | $106.37 | $1,808 |
| 99204 Office E&M - New | Office | 16 | 16 | $107.90 | $1,726 |
| 99205 Office E&M - New | Office | 15 | 15 | $160.42 | $2,406 |
| 99223 Hospital E&M - Initial | Facility | 11 | 11 | $141.27 | $1,554 |
By year: 2022 $40K for 3,145 services; 2023 $42K for 3,508 services; 2024 $59K for 4,992 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kelly L Andrzejewski prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 574 prescriptions and refills. In total Kelly L Andrzejewski wrote 2,524 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 574 | 1,344 | 162 | $42K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 201 | 499 | 60 | $9,099 |
| Rytary Carbidopa/Levodopa | 143 | 197 | 20 | $243K |
| Gabapentin Generic | 136 | 199 | 26 | $2,153 |
| Clonazepam Generic | 121 | 159 | 22 | $2,391 |
| Rasagiline Mesylate Generic | 82 | 220 | 21 | $18K |
| Amantadine Amantadine Hcl | 80 | 174 | 23 | $5,480 |
| Austedo Deutetrabenazine | 80 | 90 | Under 11 | $1.3M |
| Primidone Generic | 74 | 162 | 21 | $3,357 |
| Donepezil Hcl Generic | 69 | 163 | 15 | $1,199 |
| Ropinirole Hcl Generic | 66 | 109 | 11 | $1,868 |
| Nuplazid Pimavanserin Tartrate | 58 | 66 | Under 11 | $322K |
| Entacapone Generic | 53 | 105 | 15 | $16K |
| Topiramate Generic | 50 | 82 | 14 | $580 |
| Propranolol Hcl Generic | 48 | 108 | 15 | $1,327 |
Brand drugs: - claims; generic drugs: 2,105 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kelly L Andrzejewski $32K ($32K in general payments such as food, travel and fees) from 13 companies. The largest payer was Teva Pharmaceuticals USA, Inc. with $31K.
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. TEVA | 22 | $31K |
| Medtronic, Inc. MDT | 3 | $236 |
| MDD US Operations, LLC | 8 | $119 |
| Supernus Pharmaceuticals, Inc. SUPN | 3 | $72.29 |
| Merz Pharmaceuticals, LLC | 2 | $66.72 |
| Neurocrine BioSciences, Inc. NBIX | 2 | $39.29 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 1 | $25.51 |
| Amneal Pharmaceuticals LLC AMRX | 1 | $24.71 |
| Abbvie Inc. ABBV | 1 | $23.6 |
| Grifols USA, LLC | 1 | $23.09 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.